Galapagos NV (NASDAQ:GLPG)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $53.93, but opened at $54.49. Galapagos NV shares last traded at $55.54, with a volume of 51,241 shares traded.

A number of equities analysts have recently issued reports on GLPG shares. Zacks Investment Research cut Galapagos NV from a “buy” rating to a “hold” rating in a report on Monday, July 4th. Credit Suisse Group AG restated a “hold” rating and set a $48.00 price target on shares of Galapagos NV in a research report on Friday, June 17th. Morgan Stanley decreased their price target on Galapagos NV from $92.00 to $89.00 and set an “overweight” rating on the stock in a research report on Monday, May 2nd. Finally, Cowen and Company restated a “buy” rating on shares of Galapagos NV in a research report on Saturday, April 30th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Galapagos NV has an average rating of “Buy” and an average target price of €65.50 ($72.78).

The stock’s market cap is $2.53 billion. The company’s 50-day moving average price is $53.71 and its 200 day moving average price is $48.81.

Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.